New Acne Cream Targets Hormones

Video Credit: Wochit News
Published on August 30, 2020 - Duration: 00:34s

New Acne Cream Targets Hormones

Early next year, dermatologists could have a new weapon with which to do battle against acne.

According to Allure, the topical cream Winlevi was officially approved at the end of August by the United States Food and Drug Administration.

Winlevi, also called Clascoterone Cream 1%, is the only topical medication that targets the androgen receptors in the skin.

Androgens are hormones that are responsible for driving sebum production and inflammation.


You are here

💡 One News Page Knowledge: Other News Mentions

You might like